Skip to content
BeiGene logo

BeiGene Alternatives & Competitors

12 companies similar to BeiGene — BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

Companies similar to BeiGene

Takeda Oncology logo — alternative to BeiGene

Takeda Oncology

We aspire to cure cancer, with inspiration from patients and innovation from everywhere.

Cullinan Therapeutics logo — alternative to BeiGene

Cullinan Therapeutics

Science That Moves

Kestrel Therapeutics logo — alternative to BeiGene

Kestrel Therapeutics

We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...

2seventy bio logo — alternative to BeiGene

2seventy bio

It’s about time we think smarter and faster than cancer.

Rival Readout

Competing with BeiGene? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Arcellx logo — alternative to BeiGene

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

Umoja Biopharma logo — alternative to BeiGene

Umoja Biopharma

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...

Signet Therapeutics Inc. logo — alternative to BeiGene

Signet Therapeutics Inc.

Address Unmet Medical Needs Through Innovation.

Deciphera Pharmaceuticals logo — alternative to BeiGene

Deciphera Pharmaceuticals

A member of ONO Group

Blueprint Medicines logo — alternative to BeiGene

Blueprint Medicines

Striving to improve and extend patients' lives

BeyondSpring logo — alternative to BeiGene

BeyondSpring

Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to ad...

Clasp Therapeutics logo — alternative to BeiGene

Clasp Therapeutics

Pioneering precise immuno-oncology with next-gen T cell engagers targeting specific tumor...

Mestag Therapeutics logo — alternative to BeiGene

Mestag Therapeutics

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

About BeiGene

BeiGene, now rebranding as BeOne Medicines Ltd., is a notable player in the life sciences biotechnology sector. Founded in 2010, the company has been instrumental in developing innovative cancer therapies. The company recently changed the name of its U.S.

Services

Cancer Treatment Development, Clinical Research and Trials, Patient Assistance Programs, Biopharmaceutical Manufacturing

Target Customers

Cancer Patients, Healthcare Providers, Medical Researchers, Investors

Business keywords

Life Sciences, Innovative Medicines, Cancer Treatment, Immuno-oncology, Hematology, Oncology, Targeted Therapy, Global Rebranding, Patient Partnerships, Pharmaceutical Development, Therapeutic Innovation, Global Healthcare, Redomiciliation, Shareholder Engagement

Business Model

B2B, B2C, B2D

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Companies similar to BeiGene include Takeda Oncology, Cullinan Therapeutics, Kestrel Therapeutics, 2seventy bio, Arcellx. They share BeiGene's focus on oncology, cancer treatment and immuno-oncology.
Bounce Watch lists 12 companies that share BeiGene's industries and are closest to it in business tags, services, target customers, business model and size.
BeiGene, now rebranding as BeOne Medicines Ltd., is a notable player in the life sciences biotechnology sector. Founded in 2010, the company has been instrumental in developing innovative cancer therapies. The company recently changed the name of its U.S.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around BeiGene: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at BeiGene on 11 Mar 2026. The 12 companies listed here were last checked between 6 Mar 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout